ZC3H11B
gene geneOn this page
Summary
ZC3H11B (zinc finger CCCH-type containing 11B, HGNC:25659) is a protein-coding gene on chromosome 1q41, encoding Zinc finger CCCH domain-containing protein 11B (A0A1B0GTU1). May play a role in mRNA transport.
Predicted to enable zinc ion binding activity. Predicted to be involved in poly(A)+ mRNA export from nucleus.
Source: NCBI Gene 643136 — RefSeq curated summary.
At a glance
- GWAS associations: 49
- Clinical variants (ClinVar): 1 total
- MANE Select transcript:
NM_001355457
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:25659 |
| Approved symbol | ZC3H11B |
| Name | zinc finger CCCH-type containing 11B |
| Location | 1q41 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000215817 |
| Ensembl biotype | protein_coding |
| Entrez | 643136 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000651890
RefSeq mRNA: 1 — MANE Select: NM_001355457
NM_001355457
CCDS: CCDS86051
Canonical transcript exons
ENST00000651890 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00003844378 | 219608012 | 219612563 |
| ENSE00003847018 | 219612931 | 219613105 |
Expression profiles
Bgee: expression breadth ubiquitous, 125 present calls, max score 77.40.
Top tissues by expression
130 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 77.40 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 74.32 | gold quality |
| testis | UBERON:0000473 | 70.62 | gold quality |
| right testis | UBERON:0004534 | 70.60 | gold quality |
| left testis | UBERON:0004533 | 70.25 | gold quality |
| ventricular zone | UBERON:0003053 | 61.03 | gold quality |
| ganglionic eminence | UBERON:0004023 | 60.11 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 58.43 | gold quality |
| stromal cell of endometrium | CL:0002255 | 58.04 | gold quality |
| cortical plate | UBERON:0005343 | 55.86 | gold quality |
| heart left ventricle | UBERON:0002084 | 53.78 | gold quality |
| gastrocnemius | UBERON:0001388 | 53.03 | gold quality |
| muscle of leg | UBERON:0001383 | 52.98 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 52.87 | gold quality |
| right lobe of liver | UBERON:0001114 | 52.19 | silver quality |
| lymph node | UBERON:0000029 | 50.73 | silver quality |
| granulocyte | CL:0000094 | 50.55 | silver quality |
| primary visual cortex | UBERON:0002436 | 50.28 | gold quality |
| leukocyte | CL:0000738 | 50.11 | silver quality |
| mucosa of transverse colon | UBERON:0004991 | 49.68 | gold quality |
| vermiform appendix | UBERON:0001154 | 49.66 | gold quality |
| heart | UBERON:0000948 | 49.47 | gold quality |
| islet of Langerhans | UBERON:0000006 | 49.35 | gold quality |
| monocyte | CL:0000576 | 49.32 | silver quality |
| blood | UBERON:0000178 | 49.02 | gold quality |
| right coronary artery | UBERON:0001625 | 48.97 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 48.97 | gold quality |
| left adrenal gland | UBERON:0001234 | 48.96 | gold quality |
| duodenum | UBERON:0002114 | 48.89 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 48.71 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 5.17 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 2)
- Genetic variants in ZC3H11B, RSPO1, and GJD2 are associated with susceptibility to the development of high myopia in a Han Chinese population. (PMID:26485405)
- Association of the ZC3H11B, ZFHX1B and SNTB1 genes with myopia of different severities. (PMID:31300455)
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | zc3h11a | ENSDARG00000009754 |
| mus_musculus | Zc3h11a | ENSMUSG00000102976 |
| rattus_norvegicus | ENSRNOG00000066862 | |
| rattus_norvegicus | ENSRNOG00000075060 | |
| rattus_norvegicus | ENSRNOG00000085640 |
Paralogs (3): ZC3H11A (ENSG00000058673), C12orf50 (ENSG00000165805), ZC3H11C (ENSG00000214558)
Protein
Protein identifiers
Zinc finger CCCH domain-containing protein 11B — A0A1B0GTU1 (reviewed: A0A1B0GTU1)
All UniProt accessions (1): A0A1B0GTU1
UniProt curated annotations — full annotation on UniProt →
Function. May play a role in mRNA transport.
RefSeq proteins (1): NP_001342386* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000571 | Znf_CCCH | Domain |
| IPR041686 | Znf-CCCH_3 | Domain |
Pfam: PF15663
UniProt features (19 total): compositionally biased region 9, region of interest 6, zinc finger region 2, chain 1, coiled-coil region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-A0A1B0GTU1-F1 | 56.23 | 0.08 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 16 (showing top):
GOBP_NUCLEAR_TRANSPORT, GOBP_NUCLEOBASE_CONTAINING_COMPOUND_TRANSPORT, GOBP_NUCLEAR_EXPORT, GOBP_RNA_LOCALIZATION, GOMF_MRNA_BINDING, GOBP_RNA_EXPORT_FROM_NUCLEUS, GOBP_MRNA_EXPORT_FROM_NUCLEUS, GOBP_POLY_A_PLUS_MRNA_EXPORT_FROM_NUCLEUS, GOBP_INTRACELLULAR_TRANSPORT, GOBP_MRNA_TRANSPORT, GOBP_ESTABLISHMENT_OF_RNA_LOCALIZATION, LAMB3_TARGET_GENES, THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_28DY_UP, GOBP_NITROGEN_COMPOUND_TRANSPORT, GOBP_ESTABLISHMENT_OF_LOCALIZATION_IN_CELL
GO Biological Process (1): poly(A)+ mRNA export from nucleus (GO:0016973)
GO Molecular Function (2): zinc ion binding (GO:0008270), metal ion binding (GO:0046872)
GO Cellular Component (0):
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| mRNA export from nucleus | 1 |
| transition metal ion binding | 1 |
| cation binding | 1 |
Protein interactions and networks
STRING
346 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZC3H11B | CMSS1 | Q9BQ75 | 734 |
| ZC3H11B | GJD2 | Q9UKL4 | 623 |
| ZC3H11B | SNTB1 | Q13884 | 574 |
| ZC3H11B | ALPG | P10696 | 571 |
| ZC3H11B | LAMA2 | P24043 | 507 |
| ZC3H11B | ZNRF3 | Q9ULT6 | 507 |
| ZC3H11B | PRSS56 | P0CW18 | 479 |
| ZC3H11B | ZNF644 | Q9H582 | 447 |
| ZC3H11B | KCNQ5 | Q9NR82 | 419 |
| ZC3H11B | RSPO1 | Q2MKA7 | 418 |
| ZC3H11B | ZNF345 | Q14585 | 400 |
| ZC3H11B | MPP4 | Q96JB8 | 398 |
| ZC3H11B | LYPLAL1 | Q5VWZ2 | 390 |
| ZC3H11B | CD55 | P08174 | 356 |
| ZC3H11B | EDF1 | O60869 | 353 |
| ZC3H11B | NFAT5 | O94916 | 353 |
IntAct
0 interactions, top by confidence:
ESM2 similar proteins: A0A1B0GTU1, A2AUY4, B7ZS37, D3Z8Y2, D4A4L4, D4A666, E1B7L7, O46385, O60293, O75152, O95425, P0DQW0, Q08AZ1, Q3KQW7, Q3U1C4, Q3UH68, Q3ZC82, Q4G0F8, Q4V9H5, Q5F3Z9, Q5NBX1, Q5REG6, Q5ZJJ1, Q5ZM88, Q61464, Q62394, Q68FE9, Q6NZF1, Q6PJT7, Q6ZQ03, Q6ZU65, Q76L83, Q7TMD5, Q8BHZ4, Q8BJ05, Q8BLG0, Q8BZ32, Q8C9B9, Q8CCJ9, Q8K298
Diamond homologs: A0A1B0GTU1, O75152, P0DQW0, Q32KY7, Q4R731, Q5REG6, Q5ZJJ1, Q6AYU0, Q6NZF1, Q8NA57, Q6K977
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
1 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
0 predictions. Top by Δscore:
AlphaMissense
5242 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 1:219611817:G:C | F82L | 0.993 |
| 1:219611817:G:T | F82L | 0.993 |
| 1:219611819:A:G | F82L | 0.993 |
| 1:219611999:A:G | C22R | 0.992 |
| 1:219611991:G:C | F24L | 0.991 |
| 1:219611991:G:T | F24L | 0.991 |
| 1:219611993:A:G | F24L | 0.991 |
| 1:219612015:A:C | C16W | 0.990 |
| 1:219612017:A:G | C16R | 0.990 |
| 1:219612016:C:G | C16S | 0.989 |
| 1:219612017:A:T | C16S | 0.989 |
| 1:219612033:A:C | F10L | 0.988 |
| 1:219612033:A:T | F10L | 0.988 |
| 1:219612035:A:G | F10L | 0.988 |
| 1:219611997:G:C | C22W | 0.987 |
| 1:219612016:C:T | C16Y | 0.987 |
| 1:219612041:A:G | C8R | 0.987 |
| 1:219611998:C:G | C22S | 0.985 |
| 1:219611998:C:T | C22Y | 0.985 |
| 1:219611999:A:T | C22S | 0.985 |
| 1:219612039:G:C | C8W | 0.985 |
| 1:219611907:A:C | F52L | 0.983 |
| 1:219611907:A:T | F52L | 0.983 |
| 1:219611909:A:G | F52L | 0.983 |
| 1:219611954:A:G | C37R | 0.983 |
| 1:219612040:C:G | C8S | 0.983 |
| 1:219612041:A:T | C8S | 0.983 |
| 1:219611866:C:G | C66S | 0.982 |
| 1:219611867:A:G | C66R | 0.982 |
| 1:219611867:A:T | C66S | 0.982 |
dbSNP variants (sampled 300 via entrez): RS1000159774 (1:219613885 A>G), RS1000720775 (1:219614151 A>T), RS1000722462 (1:219607788 T>G), RS1000947571 (1:219612123 A>G), RS1001433347 (1:219613279 AG>A), RS1002410115 (1:219611585 C>A,T), RS1002439558 (1:219611212 A>C), RS1003395417 (1:219608901 A>C,G), RS1003427841 (1:219608484 T>A,G), RS1004380561 (1:219610517 A>G), RS1004688719 (1:219614476 C>T), RS1004982748 (1:219608037 A>T), RS1005086529 (1:219607556 C>A), RS1005751059 (1:219614763 A>G,T), RS1005787029 (1:219614500 T>A)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
49 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST001561_4 | Myopia (pathological) | 3.000000e-10 |
| GCST002063_9 | Sexual dimorphism in anthropometric traits | 7.000000e-16 |
| GCST002115_5 | Axial length | 1.000000e-11 |
| GCST004067_176 | Hip circumference adjusted for BMI | 3.000000e-08 |
| GCST004067_192 | Hip circumference adjusted for BMI | 4.000000e-35 |
| GCST004067_79 | Hip circumference adjusted for BMI | 1.000000e-35 |
| GCST005414_19 | Type 2 diabetes | 3.000000e-08 |
| GCST007157_5 | Corneal astigmatism | 4.000000e-10 |
| GCST007159_19 | Corneal astigmatism | 5.000000e-14 |
| GCST007160_1 | Refractive astigmatism | 2.000000e-07 |
| GCST009764_14 | Body mass index | 4.000000e-08 |
| GCST010994_3 | High myopia | 2.000000e-11 |
| GCST012226_421 | Waist circumference adjusted for body mass index | 9.000000e-11 |
| GCST012226_422 | Waist circumference adjusted for body mass index | 4.000000e-10 |
| GCST012227_1213 | Hip circumference adjusted for BMI | 9.000000e-23 |
| GCST012227_1214 | Hip circumference adjusted for BMI | 1.000000e-16 |
| GCST012227_1215 | Hip circumference adjusted for BMI | 1.000000e-11 |
| GCST012227_1218 | Hip circumference adjusted for BMI | 5.000000e-14 |
| GCST012227_1219 | Hip circumference adjusted for BMI | 1.000000e-11 |
| GCST012229_20 | Hip index | 2.000000e-11 |
| GCST012229_30 | Hip index | 2.000000e-13 |
| GCST012231_161 | A body shape index | 2.000000e-08 |
| GCST90020024_641 | A body shape index | 4.000000e-16 |
| GCST90020024_646 | A body shape index | 2.000000e-09 |
| GCST90020025_1279 | Waist-to-hip ratio adjusted for BMI | 2.000000e-12 |
| GCST90020025_1281 | Waist-to-hip ratio adjusted for BMI | 2.000000e-08 |
| GCST90020025_1282 | Waist-to-hip ratio adjusted for BMI | 2.000000e-30 |
| GCST90020025_1283 | Waist-to-hip ratio adjusted for BMI | 3.000000e-38 |
| GCST90020025_1321 | Waist-to-hip ratio adjusted for BMI | 2.000000e-37 |
| GCST90020026_692 | Hip index | 3.000000e-26 |
EFO canonical traits (9, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004207 | pathological myopia |
| EFO:0004343 | waist-hip ratio |
| EFO:0005951 | sexual dimorphism |
| EFO:0005318 | axial length measurement |
| EFO:0008039 | BMI-adjusted hip circumference |
| EFO:1002040 | Corneal astigmatism |
| EFO:0004340 | body mass index |
| EFO:0007789 | BMI-adjusted waist circumference |
| EFO:0007788 | BMI-adjusted waist-hip ratio |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
3 total (human), top 3 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| methylparaben | increases expression | 1 |
| sodium arsenite | increases expression | 1 |
| Doxorubicin | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.